Furtim Therapeutics is developing a bio-safe, long-circulation and effective protein drug funded by the National Science Foundation (NSF) Small Business Innovative Research (SBIR) program.
We use cookies to improve the experience of visitors to the CoMotion website. If you continue to use this site, we assume that you accept this. OkPrivacy policy